· Daily · Newsletters
Resonance network: Quantum InsiderSpace Insider
Insider Brief VantAI and Bristol Myers Squibb announce a strategic collaboration to discover new molecular glues for therapeutic targets using VantAI’s generative AI and Bristol Myers Squibb’s expertise in targeted protein degradation. The partnership
The daily briefing on LinkedIn. Free, one tap to follow.
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.